New heart zapping technique could offer safer AFib treatment
NCT ID NCT07575828
First seen May 09, 2026 · Last updated May 13, 2026 · Updated 1 time
Summary
This study tests a new device called PulseSelect that uses pulsed field ablation to treat atrial fibrillation (AFib), a condition where the heart beats irregularly. About 320 adults with symptomatic AFib will receive this procedure. The goal is to see if it safely and effectively restores normal heart rhythm without the need for long-term medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERSISTENT ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.